GlassScriptPhysician profile
Rafael D Gottenger
NPI 1144215617
$144,793.52
in general payments reported to CMS, 2019-2025
35 companies · $9,976 in 2025
The $9,976 reported for 2025 was more than what 95% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57K · 2020: $9,821 · 2021: $22K · 2022: $13K · 2023: $15K · 2024: $18K · 2025: $9,976.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $26K · Travel and Lodging: $8,965 · Food and Beverage: $7,590 · Education: $76.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $25,944.00 |
| Travel and Lodging | $8,964.52 |
| Food and Beverage | $7,589.68 |
| Education | $76.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $78,900.94 | 2019-2022 | |
| Abbvie INC. | $31,999.18 | 2023-2025 | |
| Kci USA, INC. | $16,726.28 | 2019-2023 | Kerramax Care, Silvercel, 3m Coban |
| Tela Bio, INC. | $5,129.24 | 2024-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Sientra, INC. | $4,236.49 | 2019-2022 | |
| Motiva USA, LLC | $2,961.36 | 2024-2025 | |
| Smith+Nephew, INC. | $1,229.71 | 2019-2021 | |
| Tepha INC | $481.02 | 2019-2020 | |
| Integra Lifesciences Corporation | $429.42 | 2023-2024 | Durasorb Monofilament Mesh, Integra, Integra Dermal Regeneration Template |
| Depuy Synthes Sales INC. | $276.95 | 2023-2025 | Na, Matrixrib |
| Davol INC. | $235.50 | 2023-2024 | Phasix Mesh, Arista Ah Flexitip |
| Ets Wound Care LLC | $231.99 | 2023-2025 | Mirragen Advanced Wound Matrix |
| Stryker Corporation | $206.49 | 2019-2024 | Spy-Phi System |
| Becton, Dickinson and Company | $181.07 | 2025 | Galaflex |
| Convatec INC. | $162.54 | 2021-2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calyxo, INC. | $144.75 | 2025 | Cvac Aspiration System |
| Musculoskeletal Transplant Foundation INC. | $138.64 | 2023 | |
| Medline Industries LP | $124.48 | 2020 | |
| Solventum Corporation | $122.81 | 2024 | Prevena |
| Vertex Pharmaceuticals Incorporated | $121.87 | 2025 | |
| Melinta Therapeutics, LLC | $120.84 | 2019 | |
| Mentor Worldwide LLC | $117.99 | 2020-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Solta Medical, A Division of Bausch Health US, LLC | $117.59 | 2021 | |
| Dilon Technologies, INC. | $110.89 | 2023 | Hemoblast Bellows |
| Pacira Pharmaceuticals Incorporated | $56.13 | 2021-2022 | |
| Sanara Medtech INC. | $46.22 | 2023 | Celleraterx |
| Bard Peripheral Vascular, INC. | $42.33 | 2021 | |
| Tei Biosciences INC | $21.71 | 2019 | |
| Kerecis Limited | $19.72 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Kowa Pharmaceuticals America, INC. | $19.08 | 2023 | Seglentis |
| Organogenesis INC. | $18.28 | 2022 | |
| Amniox Medical, INC. | $17.94 | 2019 | |
| Olympus America INC. | $15.75 | 2022 | |
| Polynovo North America LLC | $14.43 | 2022 | |
| Urgo Medical North America, LLC | $13.89 | 2023 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rafael Gottenger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.